Publications

5674 Results

Favorable outcomes for adolescents and young adults (AYA) with acute lymphoblastic leukemia (ALL): early results of US intergroup trial CALGB 10403 (Alliance)

Authors
W Stock;S Geyer;S Luger;A Advani;R Harvey;C Mullighan;C Willman;E August Parker;K Laumann;BL Sanford;G Marcucci;E Paietta;MS Tallman;FR Appelbaum;HP Erba;M Litzow;R Stone;RA Larson
Journal / Conference
Blood 124(21):796;American Society for Hematology (December 6-9, 2014, San Francisco, CA), oral;
Year
2014
Research Committee(s)
Leukemia
Study Number(s)
C10403

Determinants of fatal bleeding during induction chemotherapy for acute promyelocytic leukemia in the ATRA era

Authors
S Mantha;DA Goldman;J-W Lee;D Zannino;D Douer;H Iland;MR Litzow;EM Stein;FR Appelbaum;RA Larson;JM Rowe;MS Tallman
Journal / Conference
Blood 124(21):948; American Society for Hematology (December 6-9, 2014, San Francisco, CA), poster;
Year
2014
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9129 (INT-0129)

Telomere length recovery strongly predicts overall survival in acute promyelocytic leukemia (http://www.bloodjournal.org/content/124/21/2375)

Authors
M Baljevic;B Dumitriu;J-W Lee;E Paietta;J Racevskis;C Chen;E Stein;RE Gallagher;JM Rowe;F Appelbaum;B Powell;RA Larson;NS Young;M Tallman
Journal / Conference
Blood 124(21):2375; American Society for Hematology (December 6-9, 2014, San Francisco, CA), poster;
Year
2014
Research Committee(s)
Leukemia
Study Number(s)
C9710, SWOG-9129 (INT-0129)

SWOG S0410/CTN 0703: A phase II trial of tandem autologous stem cell transplantation (AHCT) for patients with primary progressive or recurrent Hodgkin lymphoma (HL) (ClinicalTrials.gov Identifier: NCT00233987)

Authors
E Smith;H Li;JW Friedberg;LS Constine;LM Rimsza;GG Laport;LL Popewell;DG Maloney;M Leblanc;SJ Forman;RI Fisher;P Stiff
Journal / Conference
Blood 124(21):676; American Society for Hematology (December 6-9, 2014, San Francisco, CA), oral;
Year
2014
Research Committee(s)
Lymphoma
Study Number(s)
S0410

Long term follow up of SWOG S0313: Ibritumomab Tiuxetan consolidation after 3 cycles of CHOP plus radiotherapy for high risk limited stage aggressive B-cell lymphoma (http://www.bloodjournal.org/content/124/21/4414)

Authors
DO Persky;TP Miller;JM Unger;CM Spier;S Puvvada;BD Stea;OW Press;LS Constine;KP Barton;M Leblanc;S Smith;RI Fisher;JW Friedberg
Journal / Conference
Blood 124(21):4414; American Society for Hematology (December 6-9, 2014, San Francisco, CA), poster;
Year
2014
Research Committee(s)
Lymphoma
Study Number(s)
S0313

Phase II trial of R-CHOP plus bortezomib induction therapy followed by bortezomib maintenance for previously untreated mantle cell lymphoma: SWOG 0601

Authors
B Till;H Li;S Bernstein;RI Fisher;WR Burack;L Rimsza;JD Floyd;M DaSilva;D Moore;M Leblanc;JW Friedberg
Journal / Conference
Blood 124(21):149, 2014; American Society for Hematology (December 6-9, 2014, San Francisco, CA), oral;
Year
2014
Research Committee(s)
Lymphoma
Study Number(s)
S0601

Double hit lymphoma and double positive lymphoma: subset analyses of MYC positive patients of SWOG S9704

Authors
S Puvvada;P Stiff;M Leblanc;JR Cook;BS Kahl;H Li;L Rimsza;JW Friedberg;SM Smith
Journal / Conference
Blood 124(21):1710; American Society for Hematology (December 6-9, 2014, San Francisco, CA), poster;
Year
2014
Research Committee(s)
Lymphoma
Study Number(s)
S9704

Preliminary report of a multicenter prospective phase II study of DA-EPOCH-R in MYC-rearranged aggressive B-cell lymphoma

Authors
K Dunleavy;MA Fanale;A LaCasce;A Noy;P Fabrizio;S Parekh;JW Hayslip;AS Advani;RS Lord;MJ Lechowicz;R Gaur;JW Leach;A Lucas;S Steinberg;B Kahl;JW Friedberg;RF Little;N Bartlett;W Wilson
Journal / Conference
Blood 124(21):395; American Society for Hematology (December 6-9, 2014, San Francisco, CA), oral;
Year
2014
Research Committee(s)
Lymphoma
Study Number(s)
CTSU/9177

SWOG 1211: Initial report on phase I trial of RVD-Elouzumab for newly diagnosed high risk multiple myeloma (HRMM)

Authors
S Usmani;R Sexton;S Ailawadhi;J Shah;N Callander;T Zimmerman;J Valent;MA Rosenzweig;B Lipe;J Zonder;S Fredette;P Richardson;SV Rajkumar;B Durie;A Hoering;RZ Orlowski
Journal / Conference
Blood 124:4762; American Society for Hematology (December 6-9, 2014, San Francisco, CA), poster;
Year
2014
Research Committee(s)
Myeloma
Study Number(s)
S1211

Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199

Authors
S Adams;RJ Gray;S Demaria;L Goldstein;EA Perez;LN Shulman;S Martino;M Wang;V Jones;T Saphner;A Wolff;W Wood;NE Davidson;G Sledge;J Sparano;S Badve
Journal / Conference
Journal of Clinical Oncology 32(27):2959-2967;
Year
2014
Research Committee(s)
Breast
PMID
PMID25071121
PMC
PMC4162494
Study Number(s)
E1199, E2197